Carlos E. Alfonso, M.D., FACC, FSCAI, is a board-certified interventional cardiologist and Director of the Coronary artery disease center at Baptist Health Heart and Vascular, and the director of the chronic total obstruction and complex percutaneous coronary intervention program. He has expertise in percutaneous coronary interventions, structural and valvular interventions and peripheral endovascular revascularization interventions. He is certified by the American Board of Internal Medicine in the following three areas: Internal medicine, cardiovascular disease and interventional cardiology, and also by the Certification Board of Nuclear Cardiology.

Prior to joining Baptist Health, Dr. Alfonso was an interventional cardiologist and medical director of complex percutaneous coronary intervention and chronic total occlusion at the University of Miami Health System. With its highly specialized techniques and procedures, this program became a referral site for the most challenging cases. He also helped launch a microvascular disease program using invasive and noninvasive techniques to evaluate patients with anginal symptoms in the absence of obstructive coronary disease.

In addition to his clinical expertise, Dr. Alfonso is dedicated to academics and education. He previously served as professor of medicine at the University of Miami Miller School of Medicine as well as the director of the cardiology fellowship program based at the University of Miami / Jackson Memorial Hospital. Dr. Alfonso earned his medical degree at the University of Miami Miller School of Medicine. He remained at the university for seven years of clinical training at Jackson Memorial Hospital, completing a residency in internal medicine and two fellowships, one in cardiovascular disease and the other in interventional cardiology.   He is the Cair of the Education committee for the Florida Chapter of the ACC, and serves on the planning committee for the ACC annual scientific sessions. 

Dr. Alfonso’s clinical research has focused on such minimally invasive heart procedures as transcatheter valve replacement, transcatheter aortic valve replacement and other novel structural procedures as well as the use of circulatory support devices for high-risk complex interventions and stem cell therapies for ischemic heart disease.  He is a fellow of the American College of Cardiology, the American Heart Association and the Society of Cardiac Angiography and Interventions.